Skip to main content
. Author manuscript; available in PMC: 2016 Mar 15.
Published in final edited form as: Cancer Res. 2015 Jan 16;75(6):1035–1045. doi: 10.1158/0008-5472.CAN-13-1625

Figure 6. Partial dependence of EGFRL858R-induced lung adenocarcinomas on Erbb3.

Figure 6

(A) Model for tamoxifen induced deletion of Erbb3. Mutant EGFRL858R tetra transgenic mice were fed doxycycline to induce tumors. When the tumor size reached a minimum volume of 100 mm3, experimental mice (Nkx2.1-CreERT2+) were administered tamoxifen by oral gavage at the doses of 250 mg/day for two days. Control animals were Nkx2.1-CreERT2 negative and treated with tamoxifen or Nkx2.1-CreERT2 positive treated with corn oil. After tamoxifen treatment, mice were imaged using MRI weekly for 4 weeks. The tumor burden for each group is shown in Fig. 6B. Mouse lungs were collected at the end of 4 weeks or when moribund and tumor extracts were analyzed by Western blot for the indicated proteins (Fig. 6C).